Joelle C. Boulos

585 total citations
24 papers, 454 citations indexed

About

Joelle C. Boulos is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Joelle C. Boulos has authored 24 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 5 papers in Pharmacology and 5 papers in Oncology. Recurrent topics in Joelle C. Boulos's work include Cancer therapeutics and mechanisms (5 papers), Plant chemical constituents analysis (3 papers) and Phytochemical compounds biological activities (3 papers). Joelle C. Boulos is often cited by papers focused on Cancer therapeutics and mechanisms (5 papers), Plant chemical constituents analysis (3 papers) and Phytochemical compounds biological activities (3 papers). Joelle C. Boulos collaborates with scholars based in Germany, Lebanon and Italy. Joelle C. Boulos's co-authors include Thomas Efferth, Mohamed‐Elamir F. Hegazy, Sabine M. Klauck, Mohamed E.M. Saeed, Robin I. Taleb, Costantine F. Daher, Mohamad Mroueh, Wassim N. Shebaby, Manik Chatterjee and Mirvat El‐Sibai and has published in prestigious journals such as Molecules, Journal of Ethnopharmacology and European Journal of Pharmacology.

In The Last Decade

Joelle C. Boulos

22 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joelle C. Boulos Germany 12 248 96 81 73 58 24 454
Zhongyuan Qu China 10 251 1.0× 71 0.7× 50 0.6× 63 0.9× 63 1.1× 34 481
Chirine El‐Baba Lebanon 11 249 1.0× 158 1.6× 42 0.5× 85 1.2× 91 1.6× 15 629
Xian‐Ji Piao China 14 238 1.0× 101 1.1× 80 1.0× 41 0.6× 62 1.1× 19 397
Weitian Wei China 8 170 0.7× 65 0.7× 45 0.6× 44 0.6× 54 0.9× 11 389
Huaxin Hou China 11 157 0.6× 62 0.6× 54 0.7× 61 0.8× 32 0.6× 27 329
Reyhaneh Farghadani Malaysia 11 238 1.0× 31 0.3× 69 0.9× 111 1.5× 57 1.0× 19 533
Yiqun Xia China 17 509 2.1× 69 0.7× 108 1.3× 75 1.0× 112 1.9× 25 771
Surya Kant Tripathi India 15 374 1.5× 137 1.4× 144 1.8× 122 1.7× 101 1.7× 34 784
Min Kyoung Kim South Korea 14 193 0.8× 43 0.4× 37 0.5× 75 1.0× 29 0.5× 31 505
Sowmyalakshmi Srinivasan United States 10 412 1.7× 130 1.4× 75 0.9× 120 1.6× 66 1.1× 14 825

Countries citing papers authored by Joelle C. Boulos

Since Specialization
Citations

This map shows the geographic impact of Joelle C. Boulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joelle C. Boulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joelle C. Boulos more than expected).

Fields of papers citing papers by Joelle C. Boulos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joelle C. Boulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joelle C. Boulos. The network helps show where Joelle C. Boulos may publish in the future.

Co-authorship network of co-authors of Joelle C. Boulos

This figure shows the co-authorship network connecting the top 25 collaborators of Joelle C. Boulos. A scholar is included among the top collaborators of Joelle C. Boulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joelle C. Boulos. Joelle C. Boulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Varol, Ayşegül, Joelle C. Boulos, Chunmei Jin, et al.. (2024). Inhibition of MSH6 augments the antineoplastic efficacy of cisplatin in non-small cell lung cancer as autophagy modulator. Chemico-Biological Interactions. 402. 111193–111193.
2.
3.
Rashan, Luay, Joelle C. Boulos, Mona Dawood, et al.. (2023). Molecular Modes of Action of an Aqueous Nerium oleander Extract in Cancer Cells In Vitro and In Vivo. Molecules. 28(4). 1871–1871. 6 indexed citations
4.
Boulos, Joelle C., et al.. (2023). Modes of Action of a Novel c-MYC Inhibiting 1,2,4-Oxadiazole Derivative in Leukemia and Breast Cancer Cells. Molecules. 28(15). 5658–5658. 11 indexed citations
5.
Boulos, Joelle C., et al.. (2023). The cardiac glycoside ZINC253504760 induces parthanatos-type cell death and G2/M arrest via downregulation of MEK1/2 phosphorylation in leukemia cells. Cell Biology and Toxicology. 39(6). 2971–2997. 15 indexed citations
6.
Boulos, Joelle C., Manik Chatterjee, Letian Shan, & Thomas Efferth. (2023). In Silico, In Vitro, and In Vivo Investigations on Adapalene as Repurposed Third Generation Retinoid against Multiple Myeloma and Leukemia. Cancers. 15(16). 4136–4136. 8 indexed citations
7.
Shebaby, Wassim N., et al.. (2023). The Wild Carrot (Daucus carota): A Phytochemical and Pharmacological Review. Plants. 13(1). 93–93. 16 indexed citations
8.
Boulos, Joelle C., Daniela Rigano, Carmen Formisano, et al.. (2023). Cynaropicrin disrupts tubulin and c-Myc-related signaling and induces parthanatos-type cell death in multiple myeloma. Acta Pharmacologica Sinica. 44(11). 2265–2281. 15 indexed citations
9.
Elbadawi, Mohamed, Joelle C. Boulos, Mona Dawood, et al.. (2023). The Novel Artemisinin Dimer Isoniazide ELI-XXIII-98-2 Induces c-MYC Inhibition, DNA Damage, and Autophagy in Leukemia Cells. Pharmaceutics. 15(4). 1107–1107. 5 indexed citations
10.
Boulos, Joelle C., et al.. (2023). Impact of plastic-related compounds on the gene expression signature of HepG2 cells transfected with CYP3A4. Archives of Toxicology. 98(2). 525–536. 7 indexed citations
11.
Saeed, Mohamed E.M., Joelle C. Boulos, Ellen Leich, et al.. (2022). Disruption of Lipid Raft Microdomains, Regulation of CD38, TP53, and MYC Signaling, and Induction of Apoptosis by Lomitapide in Multiple Myeloma Cells. Cancer Genomics & Proteomics. 19(5). 540–555. 8 indexed citations
12.
Saeed, Mohamed E.M., et al.. (2022). Expression of the Stem Cell Marker ABCB5 in Normal and Tumor Tissues. In Vivo. 36(4). 1651–1666. 10 indexed citations
13.
Boulos, Joelle C., Mohamed E.M. Saeed, Manik Chatterjee, et al.. (2021). Repurposing of the ALK Inhibitor Crizotinib for Acute Leukemia and Multiple Myeloma Cells. Pharmaceuticals. 14(11). 1126–1126. 19 indexed citations
14.
Boulos, Joelle C., et al.. (2020). Investigation of cancer drug resistance mechanisms by phosphoproteomics. Pharmacological Research. 160. 105091–105091. 28 indexed citations
15.
Bilia, Anna Rita, et al.. (2020). Nanocarriers to enhance solubility, bioavailability, and efficacy of artemisinins. World Journal of Traditional Chinese Medicine. 6(1). 26–26. 21 indexed citations
16.
Saeed, Mohamed E.M., Joelle C. Boulos, Daniela Rigano, et al.. (2019). Cytotoxicity of cucurbitacin E from Citrullus colocynthis against multidrug-resistant cancer cells. Phytomedicine. 62. 152945–152945. 43 indexed citations
17.
Boulos, Joelle C., et al.. (2019). Shikonin derivatives for cancer prevention and therapy. Cancer Letters. 459. 248–267. 166 indexed citations
18.
Daher, Costantine F., Kikki Bodman‐Smith, Robin I. Taleb, et al.. (2017). Antitumor activity of β-2-himachalen-6-ol in colon cancer is mediated through its inhibition of the PI3K and MAPK pathways. Chemico-Biological Interactions. 275. 162–170. 24 indexed citations
19.
Daher, Costantine F., Robin I. Taleb, Joelle C. Boulos, et al.. (2017). β-2-himachalen-6-ol protects against skin cancer development in vitro and in vivo. Journal of Pharmacy and Pharmacology. 69(11). 1552–1564. 13 indexed citations
20.
Taleb, Robin I., Paul Najm, Wassim N. Shebaby, et al.. (2016). β-2-himachalen-6-ol: A novel anticancer sesquiterpene unique to the Lebanese wild carrot. Journal of Ethnopharmacology. 190. 59–67. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhongyuan Qu Breakdown of academic impact, for papers by Chirine El‐Baba Breakdown of academic impact, for papers by Xian‐Ji Piao Breakdown of academic impact, for papers by Weitian Wei Breakdown of academic impact, for papers by Huaxin Hou Breakdown of academic impact, for papers by Reyhaneh Farghadani Breakdown of academic impact, for papers by Yiqun Xia Breakdown of academic impact, for papers by Surya Kant Tripathi Breakdown of academic impact, for papers by Min Kyoung Kim Breakdown of academic impact, for papers by Sowmyalakshmi Srinivasan
Rankless by CCL
2026